PMID- 33615447 OWN - NLM STAT- MEDLINE DCOM- 20211230 LR - 20231107 IS - 1097-0142 (Electronic) IS - 0008-543X (Print) IS - 0008-543X (Linking) VI - 127 IP - 11 DP - 2021 Jun 1 TI - Gastroesophageal reflux disease: A risk factor for laryngeal squamous cell carcinoma and esophageal squamous cell carcinoma in the NIH-AARP Diet and Health Study cohort. PG - 1871-1879 LID - 10.1002/cncr.33427 [doi] AB - BACKGROUND: Prior studies have suggested that gastroesophageal reflux disease (GERD) may be associated with risk of squamous cancers of the larynx and esophagus; however, most of these studies have had methodological limitations or insufficient control for potential confounders. METHODS: We prospectively examined the association between GERD and esophageal adenocarcinoma (EADC), esophageal squamous cell carcinoma (ESCC), and laryngeal squamous cell carcinoma (LSCC) in 490,605 participants of the NIH-AARP Diet and Health Study cohort who were 50-71 years of age at baseline. Exposure to risk factors were obtained from the baseline questionnaire. GERD diagnosis was extracted among eligible participants via linkage to Medicare diagnoses codes and then multiply imputed for non-Medicare-eligible participants. Hazard ratios (HRs) and 95% CIs of GERD were computed using Cox regression. RESULTS: From 1995 to 2011, we accrued 931 cases of EADC, 876 cases of LSCC, and 301 cases of ESCC in this cohort and estimated multivariable-adjusted HRs of 2.23 (95% CI, 1.72-2.90), 1.91 (95% CI, 1.24-2.94), and 1.99 (95% CI, 1.39-2.84) for EADC, LSCC, and ESCC, respectively. The associations were independent of sex, smoking status, alcohol intake, and follow-up time periods. We estimated that among the general population in the United States, 22.04% of people aged 50-71 years suffered from GERD. Using risk factor distributions for the United States from national survey data, 16.92% of LSCC cases and 17.32% of ESCC cases among individuals aged 50-71 years were estimated to be associated with GERD. CONCLUSION: GERD is a common gastrointestinal disorder, but future prospective studies are needed to replicate our findings. If replicated, they may inform clinical surveillance of GERD patients and suggest new avenues for prevention of these malignancies. CI - (c) 2021 American Cancer Society. FAU - Wang, Shao-Ming AU - Wang SM AUID- ORCID: 0000-0003-0420-2833 AD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. AD - Metabolic Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland. FAU - Freedman, Neal D AU - Freedman ND AD - Metabolic Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland. FAU - Katki, Hormuzd A AU - Katki HA AD - Biostatistics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. FAU - Matthews, Charles AU - Matthews C AD - Metabolic Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland. FAU - Graubard, Barry I AU - Graubard BI AD - Biostatistics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. FAU - Kahle, Lisa L AU - Kahle LL AD - Information Management Services Inc, Calverton, Maryland. FAU - Abnet, Christian C AU - Abnet CC AD - Metabolic Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland. LA - eng GR - ZIA CP010196/ImNIH/Intramural NIH HHS/United States GR - Intramural Research Program/National Cancer Institute, National Institutes of Health/ PT - Journal Article PT - Research Support, N.I.H., Intramural DEP - 20210222 PL - United States TA - Cancer JT - Cancer JID - 0374236 RN - Adenocarcinoma Of Esophagus SB - IM MH - Adenocarcinoma/epidemiology MH - Aged MH - *Esophageal Neoplasms/epidemiology MH - *Esophageal Squamous Cell Carcinoma/epidemiology MH - *Gastroesophageal Reflux/epidemiology MH - *Head and Neck Neoplasms/epidemiology MH - Humans MH - Medicare MH - Middle Aged MH - Prospective Studies MH - Risk Factors MH - *Squamous Cell Carcinoma of Head and Neck/epidemiology MH - United States/epidemiology PMC - PMC8406665 MID - NIHMS1732215 OTO - NOTNLM OT - NIH-AARP cohort OT - esophageal squamous cell carcinoma OT - gastroesophageal reflux disease (GERD) OT - laryngeal squamous cell carcinoma OT - prospective analysis COIS- Conflicts of interests All authors declare no potential conflicts of interests. EDAT- 2021/02/23 06:00 MHDA- 2021/12/31 06:00 PMCR- 2022/06/01 CRDT- 2021/02/22 06:02 PHST- 2020/11/30 00:00 [revised] PHST- 2020/10/14 00:00 [received] PHST- 2020/12/16 00:00 [accepted] PHST- 2021/02/23 06:00 [pubmed] PHST- 2021/12/31 06:00 [medline] PHST- 2021/02/22 06:02 [entrez] PHST- 2022/06/01 00:00 [pmc-release] AID - 10.1002/cncr.33427 [doi] PST - ppublish SO - Cancer. 2021 Jun 1;127(11):1871-1879. doi: 10.1002/cncr.33427. Epub 2021 Feb 22.